New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

41

AstraZeneca starts new Covid-19 prevention trials of antibody cocktail

AstraZeneca started late-stage trials of an experimental long-acting monoclonal antibody combination drug the company hopes could be used as a so-called prophylactic to prevent Covid-19 infection in at-risk people for up to 12 months.

42

Pfizer files Covid-19 vaccine application to U.S. FDA

Pfizer Inc. applied to U.S. health regulators for emergency use authorization (EUA) of the company’s Covid-19 vaccine, the first such application in a major step toward providing protection against the new coronavirus.

43

Childhood vaccine linked to less severe Covid-19, cigarette smoke raises risk

A roundup of some of the latest scientific studies on the novel coronavirus includes research on whether a childhood vaccine may help prevent severe Covid-19 and whether cigarette smoke increases cell vulnerability to Covid-19.

45

Novartis Inks $1.35 Billion Deal with Mesoblast for Remestemcel-L for Covid-19 ARDS

Novartis inked an exclusive worldwide license and collaboration deal with Australia-based Mesoblast to develop, commercialize and manufacture remestemcel-L for acute respiratory distress syndrome (ARDS), including when it is linked to Covid-19.

46

Covid-19 reinfection unlikely for at least six months, study finds

People who have had Covid-19 are highly unlikely to contract the disease again for at least six months after their first infection, according to a British study of healthcare workers on the frontline of the fight against the coronavirus pandemic.

49

FDA Grants EUA to Combination of Olumiant and Remdesivir in Hospitalized Covid-19 Patients

The U.S. Food and Drug Administration granted Emergency Use Authorization to a combination of Eli Lilly’s and Incyte’s rheumatoid arthritis drug Olumiant (baricitinib) and Gilead Sciences’ remdesivir as a treatment for hospitalized patients diagnosed with Covid-19 who require supplemental oxygen or ventilation.